We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
JRP Group | LSE:JRP | London | Ordinary Share | GB00BCRX1J15 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 135.10 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/4/2017 18:13 | Great day! Looking much better now. | fez77 | |
12/4/2017 19:30 | Errrr........No! | fez77 | |
12/4/2017 12:41 | Fingers crossed! | fez77 | |
11/4/2017 08:14 | has the worm turned finally? | qs99 | |
07/4/2017 11:22 | Salpara, re potential acquirors - there's conventional life assurers who want the mortality data on impaired lives, there's potentially foreign life companies and there are closed funds, who would be attracted by the discount to EV which is currently around 42%. On the foreign companies, PA had developed a JV in the US for care insurance and JR has a nascent South African business - neither of which are in the price in my view. | 18bt | |
07/4/2017 09:24 | With pe boys owning 39% of the business I struggle to see how they exit without negotiating a complete sale of the business. They cannot sell the 39% stake to a single investor as that would trigger a mandatory takeover offer. Placing 9% has driven the share price down dramatically so there is simply no possibility that they will be able to exit by selling down their stake into the market which leaves the possibility of a sale of the business. I don't know enough about them to really understand who might want them and more importantly what sort of price they might be willing to pay for them. | salpara111 | |
06/4/2017 06:28 | PE boys actions dictated by the life of their funds and their acquisition prices. They can't push for a sale under their agreements with the Co, but I'd expect JRP to be taken over in due course. | 18bt | |
05/4/2017 17:18 | This is getting a hiding! This drop surely can't be justified! | fez77 | |
05/4/2017 13:40 | but with most recent broker TP at £2.20, surely nearing a £1 discount looks overdone? and I would agree why would p/e boys take a near 50% discount to what brokers are calling intrinsic value? All looks a little overdone IMO, but then I am holding from an average of about 10% higher than this...GLA | qs99 | |
03/4/2017 17:13 | Last Thursday the latest version of the Continuous Mortality Investigation was launched. Broadly life expectancies produced by CMI 2016 are lower than those produced by previous versions of the model, with the reductions being particularly significant in relative terms at ages 85 onwards. If the projections are correct, this would result in significant reserve releases for most annuity writers. This would be less for those who like JRP reinsure a part of the book (c39% of reserves). | 18bt | |
02/4/2017 09:37 | the business is pretty sound but institutional investors will be focused on the huge overhang created by the two private equity owners. If it gets back to the 120 level I will take a stake as I don't think that they would be willing to sell at a discount to that price. | salpara111 | |
31/3/2017 19:36 | Yes I've been buying too - right down to 1.33. Didn't think it would drop below that. Looking for some upside now. | fez77 | |
31/3/2017 17:27 | that was the book building and placing this week, this is just the notification catching up IMO....90 day lock up now....let's hope JRP continue to deliver so in the worst case Permira / Cinven want to off load more, that there is sufficient city demand.....looks GV IMO and DYOR at these levels and have tucked more away in to my ISA | qs99 | |
31/3/2017 17:21 | Permira weighing this down, selling down to 23% now. | fez77 | |
29/3/2017 17:16 | Slowly ticking back up. Hope their brokers and IR team can convince more city types of value to be he here... be interesting if still sitting at a c40% discount to embedded value, DYOR, whether another firm will "take a look" as it were?! Happy to have topped up this morning .... gla and all IMO | qs99 | |
29/3/2017 10:08 | I liked the extra 20m from "strong investor demand" piece, despite any "flannel" that may be in that statement. Likewise the PE firms are now down significantly on shareholding, are they desperate sellers or willing to hold on for longer? We will find out once 90 day lock up is up, seems quite short which is a shame, but hopefully JRP will continue to deliver, so yield plus intrinsic value IMO DYOR over £2 and Numis £2.20 TP bodes well when you can today buy at £1.33....GLA.. | qs99 | |
29/3/2017 07:46 | "the Sellers announce that due to strong investor demand the size of the placing has been increased." 75M shares initially to 95M. Hmmm ... taken a position this morning. GLA | flagon | |
29/3/2017 07:17 | I have to confess that I didn't realise that almost 50% of the company was in the hands of private equity and that they still have almost 39% after this large dump. I guess the question is how quickly do they intend to sell down this huge stake. If they want to liquidate their position that will undoubtedly hold back the share price for the foreseeable future. I have watched this one for some time with a view to taking a stake but I am not so sure now. | salpara111 | |
29/3/2017 07:08 | and just noticed broker upgraded TP to £2.20....NUMIS I believe,,DYOR | qs99 | |
29/3/2017 07:06 | NOW we know why there was weakness in the shares IMO.....this explains a lot and hopefully overhang now cleared!DYOR | qs99 | |
28/3/2017 14:08 | To be fair to Odey they initially reported a disclosed position last May at around 140p. Rather than take profits, it appears greed got the better of them because, they elected to double up their short position at the summer lows, only to see the share-price then surge by 60%, and turn a large winning position into a loss. During the next few months as the shareprice eased, Odey began closing out at/around their average price but, then found the shareprice in the run up to the Prelims quickly get away from them and, following the strong results and encouraging outlook, they elected to avoid crystallising a heavy loss by increasing their short again. A potentially risky strategy considering the embedded value, strong results/outlook and rising market/sector. AIMHO/DYOR | mount teide | |
28/3/2017 12:54 | I really don't get the short position given its underlying value, but really appreciate your post Mount....yield will help....gla | qs99 | |
28/3/2017 12:36 | Odey Asset Management are running a short, with an average price i would estimate at around £1.30 going by their public disclosures. They are the only II with a disclosed short position. Odey capped the strong price rise on results day following the rise to £1.60 by increasing their short by a further circa 1.0m shares to 1.55%. Since then they appear to be controlling the book without increasing their short further by triggering stop losses and from year end profit taking. I'v been adding heavily under £1.40 - There is now a rising tide under JRP's market/sector - "It is easier for us to be selective with respect to the risks we take when markets are growing. The 2016 margins demonstrated this, and we remain selective in relation to new business," Rodney Cook/CEO - 10 March 2017 | mount teide | |
28/3/2017 08:01 | Puzzled at the recent falls. Recent Broker forecasts are from 160 to 220 and are nearly all Buy or Outperform. At 137/138 level surely this is a "no-brainer" Buy??? | fez77 | |
21/3/2017 12:15 | Hopefully seller now cleared? | qs99 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions